Observational Study to Develop a Predictive Score for Adverse Events Post ERCP

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The main objective of the study is: the identification of independent factors associated with an increased risk of post-ERCP complications. Other objectives are: the development of a predictive model of events post-ERCP adverse events and its validation; geographic validation of a predictive model already published in the literature using data collected during the study and the evaluation of the rate of post-ERCP AEs in the centers involved in the study.

Eligibility criteria

Qualifiers

Age >18 years

Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP

Obtaining informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

981 Participants
are grouped into 1 trial group